Q1: 2026-05-06 Earnings Summary EPS of -$0.49 misses by $0.00  |  Revenue of $83.68M (-4.90% Y/Y) beats by $4.45M Castle Biosciences, Inc. ( CSTL ) Q1 2026 Earnings Call May 6, 2026 4:30 PM EDT Company Participants Camilla Zuckero - Vice President of Investor Relations & Corporate Affairs Derek Maetzold - Founder, CEO, President & Director Frank Stokes - CFO & Treasurer Conference Call Participants Mason Carrico - Stephens Inc., Research Division Thomas Flaten - Lake Street Capital Markets, LLC, Research Division Catherine Ramsey - Robert W. Baird & Co. Incorporated, Research Division Matthew Parisi - KeyBanc Capital Markets Inc., Research Division Kyle Mikson - Canaccord Genuity Corp., Research Division Puneet Souda - Leerink Partners LLC, Research Division Presentation Operator Good afternoon, and welcome to Castle Biosciences First Quarter 2026 Conference Call. As a reminder, today's call is being recorded.…